Navigation Links
Engineered plants make potential precursor to raw material for plastics
Date:11/8/2010

UPTON, NY In theory, plants could be the ultimate green factories, engineered to pump out the kinds of raw materials we now obtain from petroleum-based chemicals. But in reality, getting plants to accumulate high levels of desired products has been an elusive goal. Now, in a first step toward achieving industrial-scale green production, scientists from the U.S. Department of Energys (DOE) Brookhaven National Laboratory and collaborators at Dow AgroSciences report engineering a plant that produces industrially relevant levels of compounds that could potentially be used to make plastics. The research is reported online in Plant Physiology, and will appear in print in the December issue.

Weve engineered a new metabolic pathway in plants for producing a kind of fatty acid that could be used as a source of precursors to chemical building blocks for making plastics such as polyethylene, said Brookhaven biochemist John Shanklin, who led the research. The raw materials for most precursors currently come from petroleum or coal-derived synthetic gas. Our new way of providing a feedstock sourced from fatty acids in plant seeds would be renewable and sustainable indefinitely. Additional technology to efficiently convert the plant fatty acids into chemical building blocks is needed, but our research shows that high levels of the appropriate feedstock can be made in plants.

The method builds on Shanklins longstanding interest in fatty acids the building blocks for plant oils and the enzymes that control their production (see related links below). Discovery of the genes that code for the enzymes responsible for so called unusual plant oil production encouraged many researchers to explore ways of expressing these genes and producing certain desired oils in various plants.

There are plants that naturally produce the desired fatty acids, called omega-7 fatty acids, in their seeds for example, cats claw vine and milkweed but their yields and growth characteristics are not suitable for commercial production, Shanklin said. Initial attempts to express the relevant genes in more suitable plant species resulted in much lower levels of the desired oils than are produced in plants from which the genes were isolated. This suggests that other metabolic modifications might be necessary to increase the accumulation of the desired plant seed oils, Shanklin said.

To overcome the problem of poor accumulation, we performed a series of systematic metabolic engineering experiments to optimize the accumulation of omega-7 fatty acids in transgenic plants, Shanklin said. For these proof-of-principle experiments, the scientists worked with Arabidopsis, a common laboratory plant.

Enzymes that make the unusual fatty acids are variants of enzymes called desaturases, which remove specific hydrogen atoms from fatty acid chains to form carbon-carbon double bonds, thus desaturating the fatty acid. First the researchers identified naturally occurring variant desaturases with desired specificities, but they worked poorly when introduced into Arabidopsis. They next engineered a laboratory-derived variant of a natural plant enzyme that worked faster and with greater specificity than the natural enzymes, which increased the accumulation of the desired fatty acid from less than 2 percent to around 14 percent.

Though an improvement, that level was still insufficient for industrial-scale production. The scientists then assessed a number of additional modifications to the plants metabolic pathways. For example, they down-regulated genes that compete for the introduced enzymes fatty acid substrate. They also introduced desaturases capable of intercepting substrate that had escaped the first desaturase enzyme as it progressed through the oil-accumulation pathway. In many of these experiments they observed more of the desired product accumulating. Having tested various traits individually, the scientists then combined the most promising traits into a single new plant.

The result was an accumulation of the desired omega-7 fatty acid at levels of about 71 percent in the best-engineered line of Arabidopsis. This was much higher than the omega-7 fatty acid levels in milkweed, and equivalent to those seen in cats claw vine. Growth and development of the engineered Arabidopsis plants was unaffected by the genetic modifications and accumulation of omega-7 fatty acid.

This proof-of-principle experiment is a successful demonstration of a general strategy for metabolically engineering the sustainable production of omega-7 fatty acids as an industrial feedstock source from plants, Shanklin said.

This general approach identifying and expressing natural or synthetic enzymes, quantifying incremental improvements resulting from additional genetic/metabolic modifications, and stacking of traits may also be fruitful for improving production of a wide range of other unusual fatty acids in plant seeds.


'/>"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
Source:Eurekalert

Related biology news :

1. Most complete beer proteome finding could lead to engineered brews
2. Engineered coral pigment helps scientists to observe protein movement
3. Native-like spider silk produced in metabolically engineered bacterium
4. Genetically engineered crops benefit many farmers, but the technology needs proper management to remain effective
5. Genetically engineered tobacco plant cleans up environmental toxin
6. Engineered tobacco plants have more potential as a biofuel
7. Bioengineered materials promote the growth of functional vasculature, new study shows
8. First genetically-engineered malaria vaccine to enter human trials
9. Genetically engineered mice yield clues to knocking out cancer
10. Engineered pig stem cells bridge the mouse-human gap
11. Breast cancer patients prefer silicone over saline implants after mastectomy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: